Researchers report a toxic form of tau protein increases following TBI, leading to the development of the same type of mental impairments seen in Alzheimer's patients.
Raman spectroscopy techniques allows researchers to take a closer look at the elusive amyloid beta.
A new study reports a molecular chaperone can inhibit a key stage in the development of Alzheimer's disease.
With the help of the Gordon supercomputer, researchers discover new ways to elucidate the creation of oligomers associated with Alzheimer's.
Researchers have discovered how synthetic molecules latch onto amyloid peptide fibrils. The discovery could help develop new therapies to halt Alzheimer's disease.
A new study suggests amylin could be a second amyloid and a new biomarker for age related dementia and Alzheimer's disease.
A new study has pinpointed a catalytic trigger for the onset of Alzheimer's disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.
Researchers found a key difference in the brains of people with Alzheimer’s disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.